Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

336.34
+3.531.06%
Post-market: 336.340.00000.00%19:30 EDT
Volume:792.68K
Turnover:266.09M
Market Cap:27.21B
PE:27.85
High:336.90
Open:332.68
Low:330.90
Close:332.81
52wk High:338.19
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:1.29
T/O Rate:0.98%
Dividend:2.88
Dividend Rate:0.86%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:3.16
PE(LYR):32.15

Loading ...

Labcorp Announces Q3 2026 Distribution of R$ 0.62 Per Unit, Payable Sept. 17

Reuters
·
Jul 13

Baird Adjusts Labcorp Price Target to $338 From $335, Maintains Outperform Rating

MT Newswires Live
·
Jul 13

Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable Sept. 11 to Holders of Record Aug. 28

MT Newswires Live
·
Jul 10

Labcorp Declares Quarterly Dividend

THOMSON REUTERS
·
Jul 10

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Evercore ISI Adjusts Price Target on Labcorp to $315 From $300

MT Newswires Live
·
Jul 07

Labcorp EVP, Diagnostics President Bryan T. Vaughn Disposes of Common Shares Worth $93,769.74

Reuters
·
Jul 06

Labcorp Holdings (LH) Expands Cancer And Liver Testing, Is It Fully Priced?

Simply Wall St.
·
Jul 06

Why Labcorp Holdings (LH) Is Up 7.7% After Expanding Advanced At-Home and Blood-Based Diagnostics

Simply Wall St.
·
Jul 03

Genfit, Labcorp Secure Medicare Coverage for Nashnext MASH Blood Test Under License Deal

Reuters
·
Jul 03

Labcorp Holdings Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 02

Labcorp to Report Q2 Results, Host Webcast Update

Reuters
·
Jul 01

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

THOMSON REUTERS
·
Jul 01

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Labcorp Holdings Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 27

Fortrea Slips After New CFO Appointment

Reuters
·
Jun 26

Does Labcorp’s New RNA At‑Home ColoSense Screening Win Shift The Bull Case For LH?

Simply Wall St.
·
Jun 24

Labcorp Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 24

Labcorp Says ColoSense Colorectal Cancer Screening Test Available Nationwide

MT Newswires Live
·
Jun 22

Labcorp Announces Nationwide Availability of Colosense®, the First FDA-Approved Rna-Based at-Home Colorectal Cancer Screening Test

THOMSON REUTERS
·
Jun 22